Tvardi Therapeutics Inc (TVRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 19,886 | 13,469 | 911 | 86 | 3,803 |
| Gross Profit | 19,886 | 13,469 | 911 | 86 | 3,803 |
| Operating Expenses | 131,565 | 90,851 | 60,396 | 58,486 | 28,991 |
| Operating Income | -111,679 | -77,382 | -59,485 | -58,400 | -25,188 |
| Other Income | 4,490 | 2,980 | 1,156 | 652 | 101 |
| Pre-tax Income | -107,189 | -74,402 | -58,329 | -57,748 | -25,087 |
| Income Tax | -816 | -389 | -204 | -468 | -397 |
| Net Income Continuous | -106,373 | -74,013 | -58,125 | -57,280 | -24,690 |
| Net Income | $-106,373 | $-74,013 | $-58,125 | $-57,280 | $-24,690 |
| EPS Basic Total Ops | -89.68 | -74.20 | -66.99 | -75.64 | -36.02 |
| EPS Basic Continuous Ops | -89.79 | -74.27 | -67.09 | -75.63 | -36.12 |
| EPS Diluted Total Ops | -89.68 | -74.20 | -66.99 | -75.64 | -36.02 |
| EPS Diluted Continuous Ops | -89.79 | -74.27 | -67.09 | -75.63 | -36.12 |
| EPS Diluted Before Non-Recurring Items | -89.69 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-112,261 | $-78,832 | $-59,572 | $-57,153 | $-24,367 |